Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the safety and efficacy of dupilumab in children with asthma have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2025-11-21